Natus Medical Incorporated (NTUS) News

Natus Medical Incorporated (NTUS): $32.70

-0.07 (-0.21%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Filter NTUS News Items

NTUS News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

NTUS News Highlights

  • NTUS's 30 day story count now stands at 2.
  • Over the past 7 days, the trend for NTUS's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
  • The most mentioned tickers in articles about NTUS are BEAT.

Latest NTUS News From Around the Web

Below are the latest news stories about Natus Medical Inc that investors may wish to consider to help them evaluate NTUS as an investment opportunity.

Natus Medical Announces Fourth Quarter 2021 Financial Results

Q4-2021 Key ResultsRevenue (millions)$128.7 • Revenue increased 8% compared to Q4 2020• Revenue increased 14% compared to full year 2020• $12.8 million in operating cash flow for Q4 2021• $63.9 million in operating cash flow for the year 2021GAAP EPS$0.05 Non-GAAP EPS$0.47 PLEASANTON, Calif., Feb. 24, 2022 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ:NTUS) (the “Company” or “Natus”), a leading provider of medical device solutions to screen, diagnose, and treat disorders affecting the b

Yahoo | February 24, 2022

Natus Medical (NTUS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Natus Medical (NTUS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Yahoo | February 17, 2022

Natus Announces Preliminary 2021 Fourth Quarter and Full Year Revenue

PLEASANTON, Calif., Jan. 10, 2022 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ:NTUS) (the “Company” or “Natus”), a leading provider of medical device solutions focused on the diagnosis and treatment of central nervous and sensory system disorders for patients of all ages, today announced preliminary 2021 fourth quarter and full year revenue. The Company expects to report revenue of approximately $127.5 to $128.5 million for the fourth quarter of 2021, and full year 2021 of $472.3 to $4

Yahoo | January 10, 2022

Natus to Participate in the 24th Annual Needham Virtual Growth Conference

PLEASANTON, Calif., Jan. 07, 2022 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ: NTUS), (the “Company” or “Natus”), a leading provider of medical device solutions focused on the diagnosis and treatment of central nervous and sensory system disorders for patients of all ages, today announced that Thomas J. Sullivan, President and Chief Executive Officer, and Drew Davies, Executive Vice President and Chief Financial Officer, will be presenting at the 24th Annual Needham Virtual Growth Con

Yahoo | January 7, 2022

Is Natus Medical Incorporated's (NASDAQ:NTUS) Stock Price Struggling As A Result Of Its Mixed Financials?

With its stock down 3.4% over the past three months, it is easy to disregard Natus Medical (NASDAQ:NTUS). We, however...

Yahoo | January 7, 2022

Tributary Capital Management, LLC Buys LHC Group Inc, Cambium Networks Corp, Avanos Medical ...

Fort Collins, CO, based Investment company Tributary Capital Management, LLC (Current Portfolio) buys LHC Group Inc, Cambium Networks Corp, Avanos Medical Inc, Integer Holdings Corp, Natus Medical Inc, sells Medpace Holdings Inc, Omnicell Inc, Boot Barn Holdings Inc, Onto Innovation Inc, AMN Healthcare Services Inc during the 3-months ended 2021Q4, according to the most recent filings of the investment company, Tributary Capital Management, LLC.

Yahoo | January 6, 2022

Miromatrix Announces Two New Board Members

EDEN PRAIRIE, Minn., Jan. 05, 2022 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save and improve patients' lives, today announced the expansion of the board and appointment of two new board members: Lisa Wipperman Heine and William P. Burke. "I am thrilled to welcome Lisa and Bill to the Miromatrix Board as we continue developing bioengineered organs to address the transpla

Yahoo | January 5, 2022

Natus Medical to Hold 2021 Fourth Quarter Financial Results Conference Call on February 25th

PLEASANTON, Calif., Jan. 03, 2022 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ: NTUS), (the “Company” or “Natus”), a leading provider of medical device solutions focused on the diagnosis and treatment of central nervous and sensory system disorders for patients of all ages, announced today that the Company will release its 2021 fourth quarter financial results after the close of the market on Thursday, February 24th. Natus management will host a conference call on Friday, February 25th

Yahoo | January 3, 2022

Natus Medical Announces Executive Transition

Thomas J. Sullivan Appointed President & Chief Executive Officer No Change To 4th Quarter Guidance PLEASANTON, Calif., Dec. 17, 2021 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ:NTUS) (the “Company” or “Natus”), a leading provider of medical device solutions focused on the diagnosis and treatment of central nervous and sensory system disorders for patients of all ages, today announced the appointment of Thomas J. Sullivan as President & Chief Executive Officer effective December 27, 20

Yahoo | December 17, 2021

Cornercap Group Of Funds Buys Alpha Metallurgical Resources Inc, Exelixis Inc, APA Corp, Sells ...

Investment company Cornercap Group Of Funds (Current Portfolio) buys Alpha Metallurgical Resources Inc, Exelixis Inc, APA Corp, TriMas Corp, TriCo Bancshares, sells Apogee Enterprises Inc, Meredith Corp, Carriage Services Inc, Culp Inc, First Busey Corp during the 3-months ended 2021Q3, according to the most recent filings of the investment company, Cornercap Group Of Funds .

Yahoo | December 16, 2021


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.5358 seconds.